Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma.
cholangiocarcinoma
genetic
genomic
mutation
radiotherapy
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
01 Dec 2021
01 Dec 2021
Historique:
received:
04
11
2021
revised:
25
11
2021
accepted:
26
11
2021
entrez:
24
12
2021
pubmed:
25
12
2021
medline:
25
12
2021
Statut:
epublish
Résumé
We have previously shown that ablative radiotherapy (A-RT) with a biologically effective dose (BED
Identifiants
pubmed: 34945742
pii: jpm11121270
doi: 10.3390/jpm11121270
pmc: PMC8703854
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Radiological Society of North America
ID : RR2111
Organisme : NCI NIH HHS
ID : U01CA196403
Pays : United States
Organisme : NCI NIH HHS
ID : U01CA200468
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA227517
Pays : United States
Organisme : Radiological Society of North America
ID : RSD1429
Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : U54CA210181-01
Pays : United States
Références
Nat Genet. 2015 Sep;47(9):1003-10
pubmed: 26258846
Sci Rep. 2018 May 8;8(1):7119
pubmed: 29740198
Int J Mol Sci. 2020 Sep 18;21(18):
pubmed: 32962091
Hepatology. 2001 Jun;33(6):1353-7
pubmed: 11391522
Gastroenterology. 2013 Apr;144(4):829-40
pubmed: 23295441
J Clin Oncol. 2020 Jan 1;38(1):1-10
pubmed: 31682550
Cancer Discov. 2017 Oct;7(10):1116-1135
pubmed: 28667006
J Gastrointest Oncol. 2019 Aug;10(4):751-765
pubmed: 31392056
Cancer. 2016 Dec 15;122(24):3838-3847
pubmed: 27622582
Cancer Res. 2018 Aug 15;78(16):4445-4451
pubmed: 29871934
Cancer. 2017 Apr 15;123(8):1354-1362
pubmed: 27984655
Lancet Oncol. 2020 Apr;21(4):531-540
pubmed: 32105622
Chin Clin Oncol. 2020 Feb;9(1):10
pubmed: 32008331
Lancet Oncol. 2020 Jun;21(6):796-807
pubmed: 32416072
J Clin Oncol. 2016 Jan 20;34(3):219-26
pubmed: 26503201
Ann Surg Oncol. 2014 Nov;21(12):3827-34
pubmed: 24889489
Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588
pubmed: 32606456
Lancet Oncol. 2020 Feb;21(2):271-282
pubmed: 31838007
Liver Cancer. 2021 Jul 19;10(5):433-450
pubmed: 34721506
Cancers (Basel). 2021 Jul 21;13(15):
pubmed: 34359560
Semin Cancer Biol. 2019 Dec;59:36-49
pubmed: 30742905
J Clin Oncol. 2016 Feb 10;34(5):460-8
pubmed: 26668346
Sci Rep. 2020 Dec 16;10(1):22087
pubmed: 33328484
Ann Oncol. 2005;16 Suppl 2:ii93-6
pubmed: 15958484
Expert Rev Gastroenterol Hepatol. 2021 May;15(5):471-474
pubmed: 33641586
Lancet Oncol. 2020 May;21(5):671-684
pubmed: 32203698
Cancer. 2016 Jul 1;122(13):1974-86
pubmed: 26950735
J Natl Cancer Inst. 2010 Jul 7;102(13):932-41
pubmed: 20513808
Ann Surg Oncol. 2020 Apr;27(4):1122-1129
pubmed: 31873931
Clin Transl Radiat Oncol. 2019 Jul 26;19:66-71
pubmed: 31517072
JCO Precis Oncol. 2018 Nov;2:1-12
pubmed: 35135097
Cancer Discov. 2013 Jun;3(6):636-47
pubmed: 23558953
Hepatobiliary Surg Nutr. 2017 Apr;6(2):105-116
pubmed: 28503558
Lancet. 2021 Jan 30;397(10272):428-444
pubmed: 33516341
Oncologist. 2016 May;21(5):594-9
pubmed: 27000463
Gastroenterology. 2012 Apr;142(4):1021-1031.e15
pubmed: 22178589
J Mol Diagn. 2018 Sep;20(5):686-702
pubmed: 29936259
N Engl J Med. 2010 Apr 8;362(14):1273-81
pubmed: 20375404
World J Gastroenterol. 2017 Jun 21;23(23):4311-4316
pubmed: 28694672